These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26863636)

  • 1. The impact of ranitidine on monocyte responses in the context of solid tumors.
    Vila-Leahey A; Rogers D; Marshall JS
    Oncotarget; 2016 Mar; 7(10):10891-904. PubMed ID: 26863636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranitidine Inhibition of Breast Tumor Growth Is B Cell Dependent and Associated With an Enhanced Antitumor Antibody Response.
    Rogers D; Vila-Leahey A; Pessôa AC; Oldford S; Marignani PA; Marshall JS
    Front Immunol; 2018; 9():1894. PubMed ID: 30158936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice.
    Vila-Leahey A; Oldford SA; Marignani PA; Wang J; Haidl ID; Marshall JS
    Oncoimmunology; 2016 Jul; 5(7):e1151591. PubMed ID: 27622015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of histamine in natural killer cell-mediated resistance against tumor cells.
    Hellstrand K; Asea A; Hermodsson S
    J Immunol; 1990 Dec; 145(12):4365-70. PubMed ID: 2147942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Angiotensin Receptor Blocker Losartan Suppresses Growth of Pulmonary Metastases via AT1R-Independent Inhibition of CCR2 Signaling and Monocyte Recruitment.
    Regan DP; Coy JW; Chahal KK; Chow L; Kurihara JN; Guth AM; Kufareva I; Dow SW
    J Immunol; 2019 May; 202(10):3087-3102. PubMed ID: 30971441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
    Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
    J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cimetidine suppresses lung tumor growth in mice through proapoptosis of myeloid-derived suppressor cells.
    Zheng Y; Xu M; Li X; Jia J; Fan K; Lai G
    Mol Immunol; 2013 May; 54(1):74-83. PubMed ID: 23220070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histaminergic regulation of natural killer cell-mediated clearance of tumour cells in mice.
    Asea A; Hermodsson S; Hellstrand K
    Scand J Immunol; 1996 Jan; 43(1):9-15. PubMed ID: 8560202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pro-tumor effect of CD200 expression is not mimicked by agonistic CD200R antibodies.
    Pilch Z; Tonecka K; Skorzynski M; Sas Z; Braniewska A; Kryczka T; Boon L; Golab J; Meyaard L; Rygiel TP
    PLoS One; 2019; 14(1):e0210796. PubMed ID: 30653571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral gene transfer of stromal cell-derived factor-1 to murine tumors induces the accumulation of dendritic cells and suppresses tumor growth.
    Fushimi T; O'Connor TP; Crystal RG
    Cancer Res; 2006 Apr; 66(7):3513-22. PubMed ID: 16585175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical in vivo imaging of the alarmin S100A9 in tumor lesions allows for estimation of the individual malignant potential by evaluation of tumor-host cell interaction.
    Becker A; Große Hokamp N; Zenker S; Flores-Borja F; Barzcyk K; Varga G; Roth J; Geyer C; Heindel W; Bremer C; Vogl T; Eisenblaetter M
    J Nucl Med; 2015 Mar; 56(3):450-6. PubMed ID: 25678492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
    Stathopoulos GT; Psallidas I; Moustaki A; Moschos C; Kollintza A; Karabela S; Porfyridis I; Vassiliou S; Karatza M; Zhou Z; Joo M; Blackwell TS; Roussos C; Graf D; Kalomenidis I
    J Natl Cancer Inst; 2008 Oct; 100(20):1464-76. PubMed ID: 18840818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis.
    Carmi Y; Rinott G; Dotan S; Elkabets M; Rider P; Voronov E; Apte RN
    J Immunol; 2011 Mar; 186(6):3462-71. PubMed ID: 21300825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment.
    Van Overmeire E; Stijlemans B; Heymann F; Keirsse J; Morias Y; Elkrim Y; Brys L; Abels C; Lahmar Q; Ergen C; Vereecke L; Tacke F; De Baetselier P; Van Ginderachter JA; Laoui D
    Cancer Res; 2016 Jan; 76(1):35-42. PubMed ID: 26573801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis.
    Stagg J; Divisekera U; Duret H; Sparwasser T; Teng MW; Darcy PK; Smyth MJ
    Cancer Res; 2011 Apr; 71(8):2892-900. PubMed ID: 21292811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors.
    Marshall NA; Galvin KC; Corcoran AM; Boon L; Higgs R; Mills KH
    Cancer Res; 2012 Feb; 72(3):581-91. PubMed ID: 22158905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
    Sirotnak FM; Otter GM; Schmid FA
    Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of ranitidine on postoperative monocyte and neutrophil granulocyte function].
    Nielsen HJ; Nielsen HI; Jensen S; Moesgaard FA
    Ugeskr Laeger; 1995 Oct; 157(44):6119-24. PubMed ID: 7483087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer.
    Gebremeskel S; LeVatte T; Liwski RS; Johnston B; Bezuhly M
    Int J Cancer; 2015 Jan; 136(1):234-40. PubMed ID: 24798403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.